BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/24/2025 9:11:35 AM | Browse: 252 | Download: 1063
Publication Name World Journal of Stem Cells
Manuscript ID 108202
Country Kazakhstan
ISSN 1948-0210 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Meta-Analysis
Article Title Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis
Manuscript Source Unsolicited Manuscript
All Author List Raisa A Aringazina, Afshin Zare, Seyyed Mojtaba Mousavi, Nurgul Abenova, Nadiar Maratovich Mussin and Amin Tamadon
ORCID
Author(s) ORCID Number
Raisa A Aringazina http://orcid.org/0000-0003-1186-7796
Afshin Zare http://orcid.org/0000-0002-1932-8773
Amin Tamadon http://orcid.org/0000-0002-0222-3035
Funding Agency and Grant Number
Funding Agency Grant Number
Clinical Variants of Metabolic Syndrome and Hormonal Mechanisms of its Formation in the Residents of Aktobe City 8/5-1-04/1-36/1
Corresponding Author Amin Tamadon, Full Professor, PhD, Department of Natural Sciences, West Kazakhstan Marat Ospanov Medical University, No. 60 Maresiev Street, Aktobe 030012, Kazakhstan. amintamaddon@yahoo.com
Key Words Type 2 diabetes mellitus; Metabolic disorders; Obesity; Insulin lessen; Insulin resistance; Cell therapy; Mesenchymal stem cell
Core Tip This comprehensive review explores the potential of mesenchymal stem cell (MSC)-based therapies, both autologous and allogeneic, for treating type 2 diabetes mellitus. The study evaluates the safety, efficacy, and therapeutic benefits of MSCs, highlighting improvements in glycemic control, reductions in insulin requirements, and enhanced β-cell function. While MSC-based therapies show promising results with minimal adverse effects, challenges remain in standardizing treatment protocols. Future research should aim to refine these therapies and assess their long-term effects through large-scale clinical trials.
Publish Date 2025-07-24 09:11
Citation

Aringazina RA, Zare A, Mousavi SM, Abenova N, Mussin NM, Tamadon A. Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis. World J Stem Cells 2025; 17(7): 108202

URL https://www.wjgnet.com/1948-0210/full/v17/i7/108202.htm
DOI https://dx.doi.org/10.4252/wjsc.v17.i7.108202
Full Article (PDF) WJSC-17-108202-with-cover.pdf